Research ExplorerScientific StaffCarsten Bokemeyer Publications

Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations
Affiliations
701 - 750 out of 794Page size: 50

Publications

  1. 2008

  2. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.

    Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Barrels, K., Horn, C., Stahl, T., Cao, Y., Milde-Langosch, K., Niendorf, A., Kröger, N., Wenzel, S., Leuwer, R., Bokemeyer, C., Hegewisch-Becker, S. & Atanackovic, D., 2008, In: BRIT J CANCER. 99, 6, p. 930-938 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway.

    Oliveira-Ferrer, L., Hauschild, J., Fiedler, W., Bokemeyer, C., Nippgen, J., Celik, I. & Schuch, G., 2008, In: J EXP CLIN CANC RES. 27, p. 86

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

    Bokemeyer, C., Oechsle, K., Honecker, F., Mayer, F., Hartmann, J. T., Waller, C. F., Böhlke, I. & Kollmannsberger, C., 2008, In: ANN ONCOL. 19, 3, p. 448-453 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma.

    Bartsch, G., Eggert, K., Soker, S., Bokemeyer, C., Hautmann, R. & Schuch, G., 2008, In: J UROLOGY. 179, 1, p. 326-332 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line.

    Glaesener, S., Honecker, F., Veltman, I. M., Gillis, A. J. M., Rohlfing, T., Streichert, T., Otto, B., Brümmendorf, T., Looijenga, L. H. J., Bokemeyer, C. & Balabanov, S., 2008, In: J PROTEOME RES. 7, 9, p. 3890-3899 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia.

    Ayuketang Ayuk, F., Atassi, N., Schuch, G., Mina, S., Fang, L., Bokemeyer, C., Fehse, B., Zander, A. R. & Kröger, N., 2008, In: LEUKEMIA RES. 32, 8, p. 1200-1206 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Erythropoietins should be used according to guidelines.

    Aapro, M. S., Birgegård, G., Bokemeyer, C., Cornes, P., Foubert, J., Gascon, P., Glaspy, J., Hellström-Lindberg, E., Link, H., Ludwig, H., Osterborg, A., Repetto, L. & Soubeyran, P., 2008, In: LANCET ONCOL. 9, 5, p. 412-413 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report

    Iwanski, G., Block, A., von Amsberg, G., Münch, J., Claus, S., Fiedler, W. & Bokemeyer, C., 2008, In: J MED CASE REP. 2, p. 115

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

    Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., Mulder, D., Pieter, H. M., Maria, D. S., de Wit, M., de Wit, R., Derigs, H. G., Dieckmann, K-P., Dieing, A., Droz, J-P., Fenner, M., Fizazi, K., Flechon, A., Fosså, S. D., Muro, D., Garcia, X., Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J. R., Gillessen, S., Hartmann, J. T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W. G., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K. U., Kollmannsberger, C., Kuczyk, M., Laguna, P., Galvis, O. L., Loy, V., Mason, M. D., Mead, G. M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G. O. N., Ares, L. P., Pizzocaro, G., Pont, J., Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H-U., Schmidberger, H., Schmoll, H-J., Schrader, M., Sedlmayer, F., Skakkebaek, N. E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L. & von der Maase, H., 2008, In: EUR UROL. 53, 3, p. 478-496 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

    Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., Mulder, D., Pieter, H. M., Maria, D. S., de Wit, M., de Wit, R., Derigs, H. G., Dieckmann, K-P., Dieing, A., Droz, J-P., Fenner, M., Fizazi, K., Flechon, A., Fosså, S. D., Muro, D., Garcia, X., Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J. R., Gillessen, S., Hartmann, J. T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W. G., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K. U., Kollmannsberger, C., Kuczyk, M., Laguna, P., Galvis, O. L., Loy, V., Mason, M. D., Mead, G. M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G. O. N., Paz-Ares, L., Pizzocaro, G., Pont, J., Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H-U., Schmidberger, H., Schmoll, H-J., Schrader, M., Sedlmayer, F., Skakkebaek, N. E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L. & von der Maase, H., 2008, In: EUR UROL. 53, 3, p. 497-513 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Gefitinib in combination with oxaliplatin and 5-fluorouracil in irinotecan-refractory patients with colorectal cancer: a phase I study of the Arbeits gemeinschaft Internistische Onkologie (AIO).

    Hartmann, J. T., Pintoffl, J. P., Kröning, H., Bokemeyer, C., Holtmann, M. & Höhler, T., 2008, In: ONKOLOGIE. 31, 5, p. 237-241 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. [Haemostatic aspects in clinical oncology]

    Langer, F., Holstein, K., Eifrig, B. & Bokemeyer, C., 2008, In: HAMOSTASEOLOGIE. 28, 5, p. 472-480 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.

    Schilling, G., Hansen, T., Shimoni, A., Zabelina, T., Pérez-Simón, J-A., Simon-Perez, J-A., Gutierrez, N. C., Fiedler, W., Liebisch, P., Schwerdtfeger, R., Bornhäuser, M., Otterstetter, S., Murga-Penas, E-M., Dierlamm, J., Ayuketang Ayuk, F., Atanackovic, D., Bacher, U., Bokemeyer, C., Zander, A. R., San Miguel, J., Miguel, J. S., Nagler, A. & Kröger, N., 2008, In: LEUKEMIA. 22, 6, p. 1250-1255 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

    Köhne, C-H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H-J., Bleiberg, H., Van Den Brande, J., Debois, M., Bethe, U. & Van Cutsem, E., 2008, In: ANN ONCOL. 19, 5, p. 920-926 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Novel algorithm for more accurate calculation of renal function in adults with cancer.

    Holweger, K., Lipp, H-P., Dietz, K., Hartmann, J. T. & Bokemeyer, C., 2008, In: ANN PHARMACOTHER. 42, 12, p. 1749-1757 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

    Gontarewicz, A., Balabanov, S., von Amsberg, G., Panse, J., Schafhausen, P., Bokemeyer, C., Fiedler, W., Moll, J. & Brümmendorf, T., 2008, In: LEUKEMIA RES. 32, 12, p. 1857-1865 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Pharmacotherapy of relapsed metastatic testicular cancer.

    Kollmannsberger, C., Honecker, F. & Bokemeyer, C., 2008, In: EXPERT OPIN PHARMACO. 9, 13, p. 2259-2272 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

    Al-Batran, S-E., Hartmann, J. T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., Schuch, G., Stoehlmacher, J., Derigs, H. G., Hegewisch-Becker, S., Grossmann, J., Pauligk, C., Atmaca, A., Bokemeyer, C., Knuth, A. & Jäger, E., 2008, In: J CLIN ONCOL. 26, 9, p. 1435-1442 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.

    Peschel, C., Hartmann, J. T., Schmittel, A., Bokemeyer, C., Schneller, F., Keilholz, U., Buchheidt, D., Millan, S., Izquierdo, M. A. & Hofheinz, R-D., 2008, In: LUNG CANCER. 60, 3, p. 374-380 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Platinum-based chemotherapy plus cetuximab in head and neck cancer.

    Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H-R., Cupissol, D., Frederic, P., Benasso, M., Vynnychenko, I., Dominique, D. R., Bokemeyer, C., Schueler, A., Amellal, N. & Hitt, R., 2008, In: NEW ENGL J MED. 359, 11, p. 1116-1127 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.

    Sammler, C., Beyer, J., Bokemeyer, C., Hartmann, J. T. & Rick, O., 2008, In: EUR J CANCER. 44, 2, p. 237-243 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.

    Schwab, M., Zanger, U. M., Marx, C., Schaeffeler, E., Klein, K., Dippon, J., Kerb, R., Blievernicht, J., Fischer, J., Hofmann, U., Bokemeyer, C. & Eichelbaum, M., 2008, In: J CLIN ONCOL. 26, 13, p. 2131-2138 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.

    Kollmannsberger, C. & Bokemeyer, C., 2008, In: CURR OPIN SUPPORT PA. 2, 3, p. 167-172 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

    Gontarewicz, A., Balabanov, S., von Amsberg, G., Colombo, R., Graziano, A., Pesenti, E., Benten, D., Bokemeyer, C., Fiedler, W., Moll, J. & Brümmendorf, T., 2008, In: BLOOD. 111, 8, p. 4355-4364 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

    Pfreundschuh, M., Schubert, J., Ziepert, M., Schmits, R., Mohren, M., Lengfelder, E., Reiser, M., Nickenig, C., Clemens, M., Peter, N., Bokemeyer, C., Eimermacher, H., Ho, A., Hoffmann, M., Mertelsmann, R., Trümper, L., Balleisen, L., Liersch, R., Metzner, B., Hartmann, F., Glass, B., Poeschel, V., Schmitz, N., Ruebe, C., Feller, A. C. & Loeffler, M., 2008, In: LANCET ONCOL. 9, 2, p. 105-116 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Stem cell factor as a novel diagnostic marker for early malignant germ cells.

    Stoop, H., Honecker, F., van de Geijn, G. J. M., Gillis, A. J. M., Cools, M. C., de Boer, M., Bokemeyer, C., Wolffenbuttel, K. P., Drop, S. L. S., de Krijger, R. R., Dennis, N., Summersgill, B., McIntyre, A., Shipley, J., Oosterhuis, J. W. & Looijenga, L. H. J., 2008, In: J PATHOL. 216, 1, p. 43-54 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.

    Aapro, M., Abraham, I., Bokemeyer, C., Ludwig, H., Macdonald, K., Soubeyran, P. & Turner, M., 2008, In: SUPPORT CARE CANCER. 16, 2, p. 193-200 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. The local cytokine and chemokine milieu within malignant effusions.

    Atanackovic, D., Cao, Y., Kim, J-W., Brandl, S., Thoem, I., Faltz, C., Hildebrandt, Y., Bartels, K., De Weerth, A., Hegewisch-Becker, S., Hossfeld, D. & Bokemeyer, C., 2008, In: TUMOR BIOL. 29, 2, p. 93-104 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.

    Langer, F., Spath, B., Haubold, K., Holstein, K., Marx, G., Wierecky, J., Brümmendorf, T., Dierlamm, J., Bokemeyer, C. & Eifrig, B., 2008, In: ANN HEMATOL. 87, 6, p. 451-457 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. 2007

  32. An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.

    Oechsle, K., Honecker, F., Kollmannsberger, C., Rick, O., Grünwald, V., Mayer, F., Hartmann, J. T. & Bokemeyer, C., 2007, In: ANTI-CANCER DRUG. 18, 3, p. 273-276 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).

    Laack, E., Thoem, I., Krüll, A., Engel-Riedel, W., Müller, T., Meissner, C., Dürk, H., Fischer, J., Gütz, S., Kortsik, C., Elbers, M., Schuch, G., Andritzky, B., Görn, M., Burkholder, I., Edler, L., Hossfeld, D. K. & Bokemeyer, C., 2007, In: LUNG CANCER. 57, 2, p. 181-186 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer.

    Burkart, C., Bokemeyer, C., Klump, B., Pereira, P., Teichmann, R. & Hartmann, J. T., 2007, In: ANTICANCER RES. 27, 4, p. 2845-2848 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Aprotinin-associated hemolytic thrombotic microangiopathy in a patient with acute myelogenous leukemia (AML) and systemic coagulopathy.

    Langer, F., Steinmetz, O., Marx, G., Amirkhosravi, A., Eifrig, B., Bokemeyer, C. & Brümmendorf, T., 2007, In: AM J HEMATOL. 82, 12, p. 1122-1124 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

    Atanackovic, D., Arfsten, J., Cao, Y., Gnjatic, S., Schnieders, F., Bartels, K., Schilling, G., Faltz, C., Wolschke, C., Dierlamm, J., Ritter, G., Eiermann, T., Hossfeld, D. K., Zander, A. R., Jungbluth, A. A., Old, L. J., Bokemeyer, C. & Kröger, N., 2007, In: BLOOD. 109, 3, p. 1103-1112 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.

    Loges, S., Butzal, M., Wellbrock, J., Schweizer, M., Fischer, U., Bokemeyer, C., Hossfeld, D. K., Schuch, G. & Fiedler, W., 2007, In: BIOCHEM BIOPH RES CO. 357, 4, p. 1016-1020 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.

    Loges, S., Clausen, H., Reichelt, U., Bubenheim, M., Erbersdobler, A., Schurr, P., Yekebas, E. F., Schuch, G., Izbicki, J. R., Pantel, K., Bokemeyer, C. & Fiedler, W., 2007, In: CLIN CANCER RES. 13, 1, p. 76-80 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma]

    Bartsch, G., Eggert, K., Soker, S., Fiedler, W., Laack, E., Volkmer, B. G., Gschwend, J., Bokemeyer, C., Hautmann, R. & Schuch, G., 2007, In: UROLOGE. 46, 9, p. 1289-1290 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

    Bokemeyer, C., Aapro, M. S., Courdi, A., Foubert, J., Link, H., Osterborg, A., Repetto, L. & Soubeyran, P., 2007, In: EUR J CANCER. 43, 2, p. 258-270 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Germ-cell tumors.

    Lorch, A., Beyer, J. & Bokemeyer, C., 2007, In: NEW ENGL J MED. 357, 17, p. 1772-1774 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

    Balabanov, S., Gontarewicz, A., Ziegler, P., Hartmann, U., Kammer, W., Copland, M., Brassat, U., Priemer, M., Hauber, I., Wilhelm, T., Schwarz, G., Kanz, L., Bokemeyer, C., Hauber, J., Holyoake, T. L., Nordheim, A. & Brümmendorf, T. H., 2007, In: BLOOD. 109, 4, p. 1701-1711 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decision support system for supportive cancer care.

    Aapro, M., Abraham, I., MacDonald, K., Soubeyran, P., Foubert, J., Bokemeyer, C., Muenzberg, M., Joanna, V. E. & Turner, M., 2007, In: SUPPORT CARE CANCER. 15, 11, p. 1325-1329 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Lectin histochemistry of metastatic adenocarcinomas of the lung.

    Thoem, I., Schult-Kronefeld, O., Burkholder, I., Goern, M., Andritzky, B., Blonski, K., Kugler, C., Edler, L., Bokemeyer, C., Schumacher, U. & Laack, E., 2007, In: LUNG CANCER. 56, 3, p. 391-397 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.

    Hartmann, J. T., Pintoffl, J. P., Al-Batran, S-E., Quietzsch, D., Meisinger, I., Horger, M., Nehls, O., Bokemeyer, C., Königsrainer, A., Jäger, E. & Kanz, L., 2007, In: ONKOLOGIE. 30, 5, p. 235-240 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. [Molecular biology studies of late recurrence of testicular cancers]

    Albers, P., Honecker, F., Rüschoff, J., Sauter, G., Müller, S. C., Büttner, R. & Bokemeyer, C., 2007, In: UROLOGE. 46, 9, p. 1185-1186 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.

    Hartmann, J. T., Gauler, T., Metzner, B., Gerl, A., Casper, J., Rick, O., Horger, M., Schleicher, J., Derigs, G., Mayer-Steinacker, R., Beyer, J., Kuczyk, M. A. & Bokemeyer, C., 2007, In: J CLIN ONCOL. 25, 36, p. 5742-5747 36.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.

    Langer, F., Chun, F., Amirkhosravi, A., Friedrich, M., Leuenroth, S., Eifrig, B., Bokemeyer, C. & Francis, J. L., 2007, In: THROMB HAEMOSTASIS. 97, 3, p. 464-470 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer.

    Welz, S., Hehr, T., Kollmannsberger, C., Bokemeyer, C., Belka, C. & Budach, W., 2007, In: INT J RADIAT ONCOL. 69, 5, p. 1429-1435 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.

    Reichmann, U., Bokemeyer, C., Wallwiener, D., Bamberg, M. & Huober, J., 2007, In: ANN ONCOL. 18, 12, p. 1981-1984 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.

    Lorch, A., Kollmannsberger, C., Hartmann, J. T., Metzner, B., Schmidt-Wolf, I. G. H., Berdel, W. E., Weissinger, F., Schleicher, J., Egerer, G., Haas, A., Schirren, R., Beyer, J., Bokemeyer, C. & Rick, O., 2007, In: J CLIN ONCOL. 25, 19, p. 2778-2784 19.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.

    Mueller, S., Hartmann, U., Mayer, F., Balabanov, S., Hartmann, J. T., Brümmendorf, T. & Bokemeyer, C., 2007, In: INVEST NEW DRUG. 25, 6, p. 519-524 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...11 12 13 14 15 16 Next